Radioimmunotherapy of colorectal cancer patients with small volume disease:: Results of an ongoing phase-I/II trial.

被引：0
|
作者：
Behr, TM
Liersch, T
Gratz, S
Schmidt, F
Canelo, R
Lorf, T
Post, S
Wörmann, B
Hiddemann, W
Becker, H
Ringe, B
Becker, W
机构：
[1] Univ Gottingen, Dept Nucl Med, D-3400 Gottingen, Germany
[2] Univ Gottingen, Dept Gen Surg, D-3400 Gottingen, Germany
[3] Univ Gottingen, Dept Transplantat Surg, D-3400 Gottingen, Germany
[4] Univ Gottingen, Dept Hematol Oncol, D-3400 Gottingen, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 1998年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
269
引用
收藏
页码：70P / 70P
页数：1
相关论文
共 50 条
  • [41] Dexamethasone, cytarabine and oxaliplatin (DHAX) in relapsed or refractory non-Hodgkin's lymphoma patients: Results of an ongoing phase II trial.
    Chau, I
    Cunningham, D
    Hill, M
    Catovsky, D
    BLOOD, 2000, 96 (11) : 140A - 140A
  • [42] An Update of a Phase I/II Trial of FOLFIRI for Colorectal Cancer Patients with Pharmacogenetic/Pharmacokinetic Analysis
    Yamashita, Keishi
    Nagashima, Fumio
    Fujita, Ken-ichi
    Yamamoto, Wataru
    Eodo, Hisashi
    Sunakawa, Yu
    Ishida, Hiroo
    Mizuno, Keiko
    Matsunaga, Mototsugu
    Araki, Kazuhiro
    Tanaka, Ryuhei
    Ichikawa, Wataru
    Miya, Toshimichi
    Narabayashi, Masaru
    Akiyama, Yuko
    Kawara, Kaori
    Ando, Yuichi
    Sasaki, Yasutsuna
    TUMOR BIOLOGY, 2008, 29 : 84 - 84
  • [43] Phase II trial of edatrexate in patients with metastatic colorectal cancer
    Clamon, GH
    Riggs, CE
    Dreicer, R
    Hohl, RJ
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (04) : 359 - 361
  • [44] 4'-DEOXYDOXORUBICIN (DXDX) - A PHASE-I TRIAL IN PATIENTS(PTS) WITH ADVANCED CANCER
    STANTON, GF
    WITTES, RE
    RAYMOND, V
    BUDMAN, D
    SHULMAN, P
    KELSEN, D
    YOUNG, CW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 153 - 153
  • [45] A PHASE-I TRIAL OF INTRAVENOUS INTERLEUKIN-6 IN PATIENTS WITH ADVANCED CANCER
    WEBER, J
    GUNN, H
    YANG, J
    PARKINSON, D
    TOPALIAN, S
    SCHWARTZENTRUBER, D
    ETTINGHAUSEN, S
    LEVITT, D
    ROSENBERG, SA
    JOURNAL OF IMMUNOTHERAPY, 1994, 15 (04): : 292 - 302
  • [46] PHASE-I TRIAL OF RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS
    VADHANRAJ, S
    ALKATIB, A
    BHALLA, R
    PELUS, L
    NATHAN, CF
    SHERWIN, SA
    OETTGEN, HF
    KROWN, SE
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) : 137 - 146
  • [47] PHASE-I TRIAL OF LIPOSOMAL MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE IN CANCER-PATIENTS
    MURRAY, JL
    KLEINERMAN, ES
    CUNNINGHAM, JE
    TATOM, JR
    ANDREJCIO, K
    LEPEZUNIGA, J
    LAMKI, LM
    ROSENBLUM, MG
    FROST, H
    GUTTERMAN, JU
    FIDLER, IJ
    KRAKOFF, IH
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1915 - 1925
  • [48] PHASE-I TRIAL OF THYMOSIN FRACTION-5 IN CANCER-PATIENTS
    FABREGA, R
    PINSKY, C
    BRAUN, D
    CHUNG, T
    KROWN, S
    OETTGEN, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 126 - 126
  • [49] PHASE-I TRIAL OF AN ORAL IMMUNOMODULATOR AND INTERFERON INDUCER IN CANCER-PATIENTS
    WITT, PL
    RITCH, PS
    REDING, D
    MCAULIFFE, TL
    WESTRICK, L
    GROSSBERG, SE
    BORDEN, EC
    CANCER RESEARCH, 1993, 53 (21) : 5176 - 5180
  • [50] PHASE-I TRIAL OF 10-DEAZA-AMINOPTERIN IN PATIENTS WITH ADVANCED CANCER
    CURRIE, VE
    WARRELL, RP
    ARLIN, Z
    TAN, C
    SIROTNAK, FM
    GREENE, G
    YOUNG, CW
    CANCER TREATMENT REPORTS, 1983, 67 (02): : 149 - 154
12345